Areas of Interest

LIVFRESH Dental Gel toothpaste
is already approved in EU

for Prevention & Treatment of Gingivitis & Periodontitis

FEATURED IN

nbc logo
abc logo
fox logo
good housekeeping logo<br />
GQ logo
WSJ logo

PLAQUE CONTROL

We have the first breakthrough in the dental industry since the introduction of fluoride in 1914.

LIVFRESH Dental Gel toothpaste is clinically proven to remove plaque 250% BETTER than a market leader.

All ingredients are edible and contain ZERO abrasives, antimicrobials, parabens, gluten, sugar, triclosan, & SLS.

LIVFRESH is commercially available in USA.

Dental get Tubes sold

# of Customers

5-Star Reviews

PERIODONTITIS

Periodontitis is serious gum disease with no current treatment. Gingivitis leads to periodontitis, which results in loss of teeth, significant discomfort/pain, and substantial decrease in quality of life. Periodontitis has been linked to dementia, Alzheimer’s and cardiac disease. 

Prevalance

64M

PATIENTS IN THE US

Clinical Stage

PHASE 2

SCHEDULED 2023

tooth-image-block

Increasing prevalence due to the aging population and the lack of availability of effective home care. According to the CDC, at least 47% of all US adults above 30 years, suffer from periodontitis.

Current standard of care are in-office treatments to slow down progression of periodontitis which can be painful, time-intensive, and expensive. Baseline treatments include scaling and root planing, and professional cleanings every 3 months. Surgery is suggested for advanced cases.

LIVFRESH Dental Gel toothpaste
Possible first affordable at-home treatment

checkmark

Double-Blind Study Shows Reduction of Pocket Depths

Pocket Depth > 4 mm are a marker for periodontitis. In the double-blind study, the LIVFRESH group showed  significant reductions in diseased pocket depths, gum inflammation, gum bleeding and dental plaque.

checkmark

Ready to launch FDA Phase 2 study

Approval would make LIVFRESH the first affordable, at-home treatment for severe gum disease in USA

80% of the Diseased Pocket Depths
Were Reduced in the LIVFRESH group

perio-chart

LIVFRESH launching anti-gingivitis toothpaste
in 2024

Relative Improvements Shown In A Double-Blind Study

gingivitis graph
30 subjects per arm with a 3-month study duration. Control is an ADA approved toothpaste containing sodium fluoride.
livfresh

Livionex is launching an anti-plaque anti-gingivitis toothpaste in 2024

monograph icon

LivFresh Stannous Fluoride will be FDA Monograph compliant

stock icon

2-5X more effective than ADA approved toothpaste